诺赛基因
SinoGenoMax
诺赛基因 www.sinogenomax.com
北京诺赛基因组研究中心有限公司作为中国最大的以基因组学为基础的生物科技公司之一,北京诺赛基因组研究中心有限公司成立于1998年9月,由北京生物技术和新医药产业促进中心与北京博大科技投资开发有限公司投资,中国医学科学院/中国协和医科大学、北京大学、中国科学院、军事医学科学院等单位参与组建。1998年10月,国家科技部批准在诺赛基因的基础上成立国家人类基因组北方研究中心,作为国家级研究基地。
诺赛基因成功参与了“国际人类基因组计划”,随后完成了一系列重要的基因组研究项目,比如致病微生物全基因组测序研究项目,中国人群SNP检测项目和其它一些疾病基因组学研究项目。
目前,诺赛基因已经从最初的DNA 测序和基因分析服务,拓展到整个分子生物学和蛋白质组学研究和服务的广泛领域。我们已经拥有多个独立的、技术精湛的研究团队,包括基因组学、蛋白组学、抗体组学和细胞学等。更为重要的是,我们拥有一套完善的质量管理体系,对我们的生产和服务进行严格的监控。2004年,诺赛基因的质量管理体系已经通过ISO 9001:2000标准验证。目前,公司正在通过ISO/IEC 17025:2005检测标准实验室能力的认证。
诺赛基因位于北京经济技术开发区,实验室面积约5000平方米,拥有员工100多名。为从事高通量实验分析、基因组学研究和蛋白组学研究配备了多套高端实验设备,包括DNA测序仪、质谱分析仪、高性能液相色谱、微阵列芯片分析仪和实验室自动工作站等。目前,公司已正式运行实验室信息管理系统(Laboratory Information Management System , LIMS),同时对样品、数据、工作流和所有的标准操作流程(Standard Operation Procedure, SOP)进行标准化管理,达到提高生产效率、产品质量和服务质量的目的,满足客户需求。
特别是在最近几年,诺赛基因已经为国内和国际上一些医院公司成功地提供了各类高质高效的服务。无论是在科学研究还是在产业化生产方面,正是我们卓有成效并得到广泛认可的工作成绩,让我们成为了国内外客户心目中最好的生物技术服务公司之一。
As one of the largest genomics-based biotech companies in China, SinoGenoMax Co.,Ltd. was incorporated in September,1998 by a joint investment from the Beijing Municipal Science & Technology Commission and Beijing Boda Sci-Tech Venture Capital Ltd. Its founding members include the Chinese Academy of Medical Sciences,Peking University,Chinese Academy of Science,and Beijing institute of Medical Sciences.The affililated institute,Chinese National Human Genome Center of Beijing (CHGB)was established in October,1998 at SinoGenoMax.
SinoGenoMax participated in the International Human Genome Sequencing Project, and has been closely involved in several major genome-related research projects such as pathogenic microorganism sequencing projects, Chinese population single nucleotide polymorphism (SNP) genotyping project, and other disease genome research projects. Originally focused on DNA sequencing and analysis, SinoGenoMax has subsequently expanded its expertise in all aspects of molecular biology and protein biology. We have built up several independent technical groups including genomics group, proteomics group, molecular biology group. In particular,we have perfected a rigorous quality management system to implement process monitoring and quality control for all the procedures we perform.We have passed ISO 9001:2000 international certification of quality management system since 2004,and now we are preparing to obtain ISO/IEC 17025:2005 accreditation of testing laboratory.
There are currently 100 employees working at SinoGenoMax located in Beijing Economic-Technological Development Area.Our 5,000 square meter laboratory building is fully equipped with top class facilities including DNA Sequencers,mass spectrometry,HPLC,Microarray Chip Reader,and lab automation workstation,for high throughput operation and analysis in genomics and proteomics research.A proprietary Laboratory Information Management System(LIMS) has been implemented for standardized management of samples,data and work flow, and all procedures are performed under the guidance of corresponding SOPs.
In the past few years, SinoGenoMax has successfully provided high quality and cost-effective services for several international pharmaceutical companies.Wether in the scientific reaserch or industrial of production, the widely recognized achievements make us become the best biotechnology service company at home and abroad.